Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Griesinger

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
Journal of Cancer Research and Clinical Oncology|September 24, 2018
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancerJan A Stratmann, Sebastian Michels, Sofia Hornetz, et al.
Cancers|April 26, 2025
Detection of <i>ESR1</i> Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 PatientsSrushti Borkar, Fenja Markus, Agnes Oetting, et al.
Leukemia Research|January 17, 2002
Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1Detlef Haase, Claudia Binder, Jürgen Bünger, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)Balazs Halmos, Eng-Huat Tan, Ross A Soo, et al.
Future Oncology (London, England)|March 12, 2019
I-O Optimise: a novel multinational real-world research platform in thoracic malignanciesSimon Ekman, Frank Griesinger, Paul Baas, et al.
JAMA Oncology|September 5, 2018
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical TrialCesare Gridelli, Javier de Castro Carpeno, Anne-Marie C Dingemans, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2017
Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor SpecimensJudith N Müller, Markus Falk, Jatin Talwar, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Decision Conflicts in Clinical Care during COVID-19: A Multi-Perspective InquiryJoerg Haier, Johannes Beller, Kristina Adorjan, et al.
Cancers|July 1, 2020
Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung CancerStefanie Schatz, Markus Falk, Balázs Jóri, et al.
Healthcare (Basel, Switzerland)|June 24, 2022
Decision Conflicts in Clinical Care during COVID-19: A Patient PerspectiveJörg Haier, Johannes Beller, Kristina Adorjan, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
Journal of Cancer Research and Clinical Oncology|September 24, 2018
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancerJan A Stratmann, Sebastian Michels, Sofia Hornetz, et al.
Cancers|April 26, 2025
Detection of <i>ESR1</i> Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 PatientsSrushti Borkar, Fenja Markus, Agnes Oetting, et al.
Leukemia Research|January 17, 2002
Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1Detlef Haase, Claudia Binder, Jürgen Bünger, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)Balazs Halmos, Eng-Huat Tan, Ross A Soo, et al.
Future Oncology (London, England)|March 12, 2019
I-O Optimise: a novel multinational real-world research platform in thoracic malignanciesSimon Ekman, Frank Griesinger, Paul Baas, et al.
JAMA Oncology|September 5, 2018
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical TrialCesare Gridelli, Javier de Castro Carpeno, Anne-Marie C Dingemans, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2017
Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor SpecimensJudith N Müller, Markus Falk, Jatin Talwar, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Decision Conflicts in Clinical Care during COVID-19: A Multi-Perspective InquiryJoerg Haier, Johannes Beller, Kristina Adorjan, et al.
Cancers|July 1, 2020
Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung CancerStefanie Schatz, Markus Falk, Balázs Jóri, et al.
Healthcare (Basel, Switzerland)|June 24, 2022
Decision Conflicts in Clinical Care during COVID-19: A Patient PerspectiveJörg Haier, Johannes Beller, Kristina Adorjan, et al.
Pageof 16